Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: chair (216), bench (7)

Mallet finger injuries - patient information

Description: This factsheet explains what a mallet finger injury is, how it is treated and how to care for your finger while
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Mallet-finger-injuries-1817-PIL.pdf

Total knee replacement HHFT - patient information

Description: Welcome to your guide to total knee replacement (TKR) surgery.
Url: /Media/UHS-website-2019/Patientinformation/Muscles,jointsandbones/Total-knee-replacement-HHFT-4037-PIL.pdf

Your hepatitis C treatment - Zepatier® - patient information

Description: This factsheet explains how hepatitis C is treated with a medication called Zepatier®.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Your-hepatitis-C-treatment-Zepatier®-1595-PIL.pdf

Maviret for hepatitis C - patient information

Description: Maviret® is a combination tablet that contains two drugs (Glecaprevir 100mg and Pibrentasvir 40mg).It is used to treat Hepatitis C
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Maviret-for-hepatitis-C-1769-PIL.pdf

Your hepatitis C treatment (Epclusa with/without Ribavirin) - patient information

Description: You are starting a course of Epclusa® with/without ribavirin to treat your hepatitis C infection. These medications are taken in
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Your-hepatitis-C-treatment-Epclusa-withwithout-Ribavirin-1621-PIL.pdf

Hepatitis C - Harvoni® with or without ribavirin - patient information

Description: Patient information factsheet Your hepatitis C treatment Harvoni® We have given you this factsheet because you have been diagnosed with hepatitis
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Hepatitis-C-Harvoni®-with-or-without-ribavirin-1258-PIL.pdf

Gastroscopy and dilatation of oesophageal stricture (G3) aftercare advice - patient information

Description: This factsheet explains what to expect after having a gastroscopy and dilatation of oesophageal stricture.
Url: /Media/UHS-website-2019/Patientinformation/Endoscopy/Gastroscopy-and-dilatation-of-oesophageal-stricture-G3-aftercare-advice-991-PIL.pdf

Gastroscopy – throat spray (G2) aftercare advice - patient information

Description: This factsheet explains what to expect after having a gastroscopy with throat spray.
Url: /Media/UHS-website-2019/Patientinformation/Endoscopy/Gastroscopy-–-throat-spray-G2-aftercare-advice-990-PIL.pdf

Iron supplements - patient information

Description: We have recommended that you take iron supplements because you are anaemic, or at risk of developing anaemia, because the iron
Url: /Media/UHS-website-2019/Patientinformation/Blooddisorders/Iron-supplements-1533-PIL.pdf

Erlotinib

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ERLOTINIB Regimen NSCLC - Erlotinib Indication Second line therapy of stag
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Erlotinibver12.pdf

111 to 120 of 228

Previous … 10 11 12 13 14 … Next